Product Recalls in Maryland

Product recalls affecting Maryland — including food, drugs, consumer products, medical devices, and vehicles distributed to Maryland. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,871 recalls have been distributed to Maryland in the last 12 months.

52,535 total recalls
2,871 in last 12 months

Showing 60016020 of 13,385 recalls

DrugMarch 1, 2019· Apotex Inc.

Recalled Item: Drospirenone and Ethinyl Estradiol Tablets Recalled by Apotex Inc. Due to...

The Issue: Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 1, 2019· AVKARE Inc.

Recalled Item: Oxybutynin Chloride Extended-Release Tablets USP 10 mg Recalled by AVKARE...

The Issue: Failed Dissolution Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 1, 2019· Legacy Pharmaceutical Packaging LLC

Recalled Item: Losartan Potassium Tablets Recalled by Legacy Pharmaceutical Packaging LLC...

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 1, 2019· Legacy Pharmaceutical Packaging LLC

Recalled Item: Losartan Potassium Tablets Recalled by Legacy Pharmaceutical Packaging LLC...

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 1, 2019· Legacy Pharmaceutical Packaging LLC

Recalled Item: Losartan Potassium Tablets Recalled by Legacy Pharmaceutical Packaging LLC...

The Issue: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 1, 2019· American Health Packaging

Recalled Item: Aspirin and Extended-release Dipyridamole Capsules Recalled by American...

The Issue: Failed Impurities/Degradation Specifications; out of specification result...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets Recalled by Torrent Pharma...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets Recalled by Torrent Pharma...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP Recalled by Camber Pharmaceuticals Inc Due to...

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP Recalled by Camber Pharmaceuticals Inc Due to...

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Camber Pharmaceuticals Inc

Recalled Item: Losartan Potassium Tablets USP Recalled by Camber Pharmaceuticals Inc Due to...

The Issue: CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: LOSARTAN POTASSIUM TABLETS Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2019· Torrent Pharma Inc.

Recalled Item: Losartan Potassium / Hydrochlorothiazide Tablets Recalled by Torrent Pharma...

The Issue: CGMP Deviations: FDA lab confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 26, 2019· Lupin Pharmaceuticals Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution USP Recalled by Lupin Pharmaceuticals Inc....

The Issue: Failed Impurities/Degradation Specifications: Expansion of July 2018 and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugFebruary 25, 2019· Macleods Pharma Usa Inc

Recalled Item: Telmisartan and Hyrdochlorothiazide Tablets 80 mg/25 mg Recalled by Macleods...

The Issue: Failed Content Uniformity Specifications: The product is out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 25, 2019· Macleods Pharma Usa Inc

Recalled Item: Telmisartan and Hyrdochlorothiazide Tablets Recalled by Macleods Pharma Usa...

The Issue: Failed Content Uniformity Specifications: The product is out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 25, 2019· Macleods Pharma Usa Inc

Recalled Item: Telmisartan and Hyrdochlorothiazide Tablets 40mg/12.5 mg Recalled by...

The Issue: Failed Content Uniformity Specifications: The product is out of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 22, 2019· Ascend Laboratories LLC

Recalled Item: Tamsulosin Hydrochloride Capsules Recalled by Ascend Laboratories LLC Due to...

The Issue: Failed Dissolution Specifications: High Out-of-Specification dissolution...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund